Thanks to @bradloncar and @BiotechTV for the opportunity to discuss our approach and pipeline!
BiotechTV
@BiotechTV
Sep 15
𝐇𝐂𝐖 πŸπŸŽπŸπŸ”: @scribetx which represents the next generation of CRISPR, had its IPO in July - the first clinical program targets PCSK9. With Co-Founder & CEO @BenjaminLOakes. $SCTX Full video: biotechtv.com/post/scribe-th…

Sep 15, 2026 Β· 7:40 PM UTC

1
3
10
794
Sort replies: Relevant Recent Liked
Replying to @BenjaminLOakes @bradloncar @BiotechTV
Congrats on the IPO! I'm curious if epigenetic silencing at PCSK9 means you can dial it up or down like a statin dose... would be interesting indeed. Reversibility as a feature could change the risk calculus for cardio targets
24